Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

ClinicalTrials.gov ID: NCT05835466

Public ClinicalTrials.gov record NCT05835466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium [MPN-RC 120]

Study identification

NCT ID: NCT05835466
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Enrollment: 10 participants

Conditions and interventions

Conditions

Interventions

reparixin Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 23, 2023
Primary completion: Dec 30, 2027
Completion: Nov 30, 2028
Last update posted: May 5, 2026

2023 – 2028

United States locations

U.S. sites: 9
U.S. states: 5
U.S. cities: 7

Facility	City	State	ZIP	Site status
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Emory University	Atlanta	Georgia	30322	Recruiting
Roswell Park Cancer Institute	Buffalo	New York	14263	Recruiting
Ruttenberg Treatment Center	New York	New York	10029	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
NewYork-Presbyterian/Weill Cornell Medical Center	New York	New York	10065	Recruiting
Wake Forest Baptist Health Comprehensive Cancer Center	Winston-Salem	North Carolina	27157	Recruiting
The Cleveland Clinic Foundation	Cleveland	Ohio	44195	Recruiting
The Ohio State University	Columbus	Ohio	43210	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05835466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 5, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05835466 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →